Výsledky vyhledávání - "Silvia Valtorta* 1"

Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling

Publikováno v: Cancer & Metabolism, Vol 8, Iss 1, Pp 1-15 (2020)
Cancer & metabolism 8 (2020): 22. doi:10.1186/s40170-020-00227-4
info:cnr-pdr/source/autori:Daniela Gaglio 1,2, Marcella Bonanomi 2,3, Silvia Valtorta 1,2,4, Rohit Bharat 23, Marilena Ripamonti 1,2, Federica Conte 2,5, Giulia Fiscon 2,5, Nicole Righi 2,3, Elisabetta Napodano 1,2, Federico Papa 2,5, Isabella Raccagni 1,2,6, Seth J Parker 7,8, Ingrid Cifola 9, Tania Camboni 9, Paola Paci 2,5,10, Anna Maria Colangelo 2,3, Marco Vanoni 2,3, Christian M Metallo 7,8, Rosa Maria Moresco 1,2,4, Lilia Alberghina 2,3/titolo:Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling/doi:10.1186%2Fs40170-020-00227-4/rivista:Cancer & metabolism/anno:2020/pagina_da:22/pagina_a:/intervallo_pagine:22/volume:8
Cancer & Metabolism

Abstract Background Rewiring of metabolism induced by oncogenic K-Ras in cancer cells involves both glucose and glutamine utilization sustaining enhanced, unrestricted growth. The development of effective anti-cancer treatments targeting metabolism m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::950f4c1a96c7b0580200136e0d3aea0e
http://link.springer.com/article/10.1186/s40170-020-00227-4

Zobrazit plný text záznamu

Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation

Autor: Sara Belloli 1, 2, Michele Morari 3, Valentina Murtaj 2, 4, Silvia Valtorta 1, 5, Rosa Maria Moresco 1, Maria Carla Gilardi 1

Publikováno v: Frontiers in aging neuroscience 12 (2020): 152. doi:10.3389/fnagi.2020.00152
info:cnr-pdr/source/autori:Sara Belloli 1,2, Michele Morari 3, Valentina Murtaj 2,4, Silvia Valtorta 1,2,5, Rosa Maria Moresco 1,2,5 and Maria Carla Gilardi 1,5/titolo:Translation Imaging in Parkinson's Disease: Focus on Neuroinflammation/doi:10.3389%2Ffnagi.2020.00152/rivista:Frontiers in aging neuroscience/anno:2020/pagina_da:152/pagina_a:/intervallo_pagine:152/volume:12
Frontiers in Aging Neuroscience, Vol 12 (2020)
Frontiers in Aging Neuroscience

Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and the appearance of α-synuclein insoluble aggregates known as Lewy bodies. Neurodegeneration is accompanied by neuroinflamma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7149142c9831865655a3b5262309e468

Zobrazit plný text záznamu

Metabolic Evaluation of Non–Small Cell Lung Cancer Patient–Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response

Autor: Silvia Valtorta* 1, 2, Massimo Moro* 3, Giovanna Prisinzano 1, 4, Giulia Bertolini 3, Monica Tortoreto 5, Isabella Raccagni 2, Ugo Pastorino 6, Luca Roz 3, Gabriella Sozzi +3, Rosa Maria Moresco +2, 4 *Contributed equally to this work. +Contributed equally to this work.

Publikováno v: The Journal of nuclear medicine (1978) 58 (2017): 42–47. doi:10.2967/jnumed.116.176404
info:cnr-pdr/source/autori:Silvia Valtorta* 1,2, Massimo Moro* 3, Giovanna Prisinzano 1,4, Giulia Bertolini 3, Monica Tortoreto 5, Isabella Raccagni 2,4, Ugo Pastorino 6, Luca Roz 3, Gabriella Sozzi +3 and Rosa Maria Moresco +2,4 *Contributed equally to this work. +Contributed equally to this work./titolo:Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response./doi:10.2967%2Fjnumed.116.176404/rivista:The Journal of nuclear medicine (1978)/anno:2017/pagina_da:42/pagina_a:47/intervallo_pagine:42–47/volume:58
The Journal of nuclear medicine (1978. Online) (2016). doi:10.2967/jnumed.116.176404
info:cnr-pdr/source/autori:Silvia Valtorta, Massimo Moro, Giovanna Prisinzano, Giulia Bertolini, Monica Tortoreto, Isabella Raccagni, Ugo Pastorino, Luca Roz, Gabriella Sozzi, and Rosa Maria Moresco/titolo:Metabolic evaluation of non-small cell lung cancer patient-derived xenografts models using [18F]FDG PET: potential tools for early therapy response/doi:10.2967%2Fjnumed.116.176404/rivista:The Journal of nuclear medicine (1978. Online)/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume

PURPOSE: Lung cancer heterogeneity makes response to therapy extremely hard to predict. Patient-derived xenografts (PDXs) represent a reliable preclinical model that closely recapitulates the main characteristics of the primary tumor and could repres

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10070ebc3b8ac5b4544bfee6a7ebc525
https://doi.org/10.2967/jnumed.116.176404

Zobrazit plný text záznamu

Metformin and Temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models

Publikováno v: Oncotarget (2017).
info:cnr-pdr/source/autori:Silvia Valtorta 1,2,3,4,*, Alessia Lo Dico 5,*, Isabella Raccagni 1,2,3,4, Daniela Gaglio 2,4, Sara Belloli 2,3,4, Letterio S. Politi 6,7,8, Cristina Martelli 5, Cecilia Diceglie 5,1, Marcella Bonanomi 4, Giulia Ercoli 9, Valentina Vaira 5,9, Luisa Ottobrini 2,5,* and Rosa Maria Moresco 1,2,3,4,*/titolo:Metformin and Temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models/doi:/rivista:Oncotarget/anno:2017/pagina_da:/pagina_a:/intervallo_pagine:/volume

Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor with poor survival. Cytoreduction in association with radiotherapy and temozolomide (TMZ) is the standard therapy, but response is heterogeneous and life expectancy is limited.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::7ffbe54f58bfb27b307ca2d8e493dcce
https://publications.cnr.it/doc/379984

Zobrazit plný text záznamu

Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: A PET imaging and metabolomics-mass-spectrometry study

Publikováno v: Oncotarget
Oncotarget 7 (2016): 52017–52031. doi:10.18632/oncotarget.10470
info:cnr-pdr/source/autori:Daniela Gaglio 1,2,6,8, Silvia Valtorta 1,2,3,4, Marilena Ripamonti 1,2, Marcella Bonanomi 2, Chiara Damiani 2, Sergio Todde 5, Alfredo Simone Negri 6, Francesca Sanvito 7, Fabrizia Mastroianni 2, Antonella Di Campli 8, Gabriele Turacchio 8, Giuseppe Di Grigoli 1,2,3, Sara Belloli 1,2,3, Alberto Luini 8, Maria Carla Gilardi 1,2, Anna Maria Colangelo 2,9, Lilia Alberghina 2,9,*, Rosa Maria Moresco 2,3,4,*/titolo:Divergent in vitro%2Fin vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study./doi:10.18632%2Foncotarget.10470/rivista:Oncotarget/anno:2016/pagina_da:52017/pagina_a:52031/intervallo_pagine:52017–52031/volume:7

// Daniela Gaglio 1, 2, 6, 8 , Silvia Valtorta 1, 2, 3, 4 , Marilena Ripamonti 1, 2 , Marcella Bonanomi 2 , Chiara Damiani 2 , Sergio Todde 5 , Alfredo Simone Negri 6 , Francesca Sanvito 7 , Fabrizia Mastroianni 2 , Antonella Di Campli 8 , Gabriele T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::208f8a2016f679f3ba7748d6357d2218
http://hdl.handle.net/10281/119849

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání